GlassScriptPhysician profile
Urwah Haq
NPI 1366844870
$948.13
in general payments reported to CMS, 2019-2025
20 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.61 · 2020: $13.54 · 2021: $18.77 · 2022: $379 · 2023: $172 · 2024: $112 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $180.64 | 2022-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $115.70 | 2022-2025 | Nuzyra |
| Grt US Holding, INC. | $74.61 | 2022 | |
| Stryker Corporation | $65.09 | 2019-2022 | |
| Smith+Nephew, INC. | $57.12 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Solventum Corporation | $56.82 | 2024-2025 | Activ.A.C., Promogran Prisma |
| Eclipse Technology Solutions INC. | $54.35 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $45.40 | 2022 | |
| Kerecis Limited | $43.87 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Averitas Pharma INC. | $33.95 | 2023 | Qutenza |
| Depuy Synthes Sales INC. | $32.97 | 2023 | N/A, Speed |
| Globus Medical, INC. | $32.29 | 2025 | Senza |
| Treace Medical Concepts, INC. | $26.19 | 2024 | |
| Medtronic, INC. | $21.76 | 2025 | Inceptiv |
| Kci USA, INC. | $21.09 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $20.54 | 2022 | |
| Baudax Bio INC. | $18.77 | 2021 | |
| Amgen INC. | $16.77 | 2024 | Krystexxa |
| Abbott Laboratories | $16.66 | 2023 | Octrode |
| Medartis INC. | $13.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Urwah Haq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.